Karl Claxton

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 8

Top Topics

Nlrp Inflammasome

Top Venues

Health economics

BMJ global health

Health technology assessment (Winchester, England)

This page only lists publications with an associated author ORCID identifier.

Publications

Bethan Woods, James Lomas, Mark Sculpher, Helen Weatherly, Karl Claxton
Achieving dynamic efficiency in pharmaceutical innovation: Identifying the optimal share of value and payments required. Health economics 33 (4) (2024)
Bethan Woods, James Lomas, Mark Sculpher, Helen Weatherly, Karl Claxton
Achieving dynamic efficiency in pharmaceutical innovation: Identifying the optimal share of value and payments required. Health economics (2024)
Bethan Woods, James Lomas, Mark Sculpher, Helen Weatherly, Karl Claxton
Achieving dynamic efficiency in pharmaceutical innovation: Identifying the optimal share of value and payments required. Health economics 33 (4) (2024)
Jessica Ochalek, Kaja M Abbas, Karl Claxton, Mark Jit, James Lomas
Assessing the value of human papillomavirus vaccination in Gavi-eligible low-income and middle-income countries. BMJ global health 5 (10) (2021)
Laura Bojke, Marta O Soares, Karl Claxton, Abigail R Colson, Aimée Fox, Christopher H Jackson, Dina Janković, Alexander D Morton, Linda D Sharples, Andrea L Taylor
Developing a reference protocol for structured expert elicitation in health-care decision-making: a mixed-methods study. Health technology assessment (Winchester, England) 25 (37) (2021)
Bethan Woods, Aimée Fox, Mark Sculpher, Karl Claxton
Estimating the shares of the value of branded pharmaceuticals accruing to manufacturers and to patients served by health systems. Health economics 30 (11) (2021)
Francesco Longo, Karl Claxton, James Lomas, Stephen Martin
Does public long-term care expenditure improve care-related quality of life of service users in England? Health economics 30 (10) (2021)
Karl Claxton
Comment: Positive tails and normative dogs. Health economics 27 (10) (2018)